Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead

Novartis CEO Vas Narasimhan has a plan to make the global pharma giant more profitable. And he’s starting by carving out a billion dollars-plus in …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

No­var­tis CEO Vas Narasimhan re­struc­tures the phar­ma gi­ant, cut­ting costs $1B+, oust­ing top ex­ecs and sig­nal­ing lay­offs ahead